Compare ALEMBIC PHARMA with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA SHASUN PHARMA ALEMBIC PHARMA/
SHASUN PHARMA
 
P/E (TTM) x 16.8 123.9 13.5% View Chart
P/BV x 6.7 8.5 78.0% View Chart
Dividend Yield % 0.6 0.2 245.6%  

Financials

 ALEMBIC PHARMA   SHASUN PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
SHASUN PHARMA
Mar-14
ALEMBIC PHARMA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs66494 704.9%   
Low Rs41246 904.4%   
Sales per share (Unadj.) Rs208.7214.2 97.4%  
Earnings per share (Unadj.) Rs31.05.3 580.9%  
Cash flow per share (Unadj.) Rs37.115.8 234.6%  
Dividends per share (Unadj.) Rs5.501.00 550.0%  
Dividend yield (eoy) %1.01.4 71.4%  
Book value per share (Unadj.) Rs144.253.3 270.4%  
Shares outstanding (eoy) m188.5256.62 333.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.3 790.1%   
Avg P/E ratio x17.413.1 132.5%  
P/CF ratio (eoy) x14.54.4 328.2%  
Price / Book Value ratio x3.71.3 284.8%  
Dividend payout %17.718.7 94.7%   
Avg Mkt Cap Rs m101,4613,958 2,563.6%   
No. of employees `000NANA-   
Total wages/salary Rs m7,4672,164 345.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m39,34712,127 324.5%  
Other income Rs m94229 40.9%   
Total revenues Rs m39,44112,356 319.2%   
Gross profit Rs m8,7361,009 865.7%  
Depreciation Rs m1,152594 194.1%   
Interest Rs m184415 44.4%   
Profit before tax Rs m7,493230 3,262.2%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930 30,933.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568-73 -2,155.5%   
Profit after tax Rs m5,844302 1,934.2%  
Gross profit margin %22.28.3 266.8%  
Effective tax rate %20.9-31.7 -66.1%   
Net profit margin %14.92.5 596.1%  
BALANCE SHEET DATA
Current assets Rs m19,5776,884 284.4%   
Current liabilities Rs m14,8968,456 176.2%   
Net working cap to sales %11.9-13.0 -91.8%  
Current ratio x1.30.8 161.4%  
Inventory Days Days9062 145.6%  
Debtors Days Days45108 42.2%  
Net fixed assets Rs m27,0974,970 545.2%   
Share capital Rs m377113 332.7%   
"Free" reserves Rs m26,8112,875 932.6%   
Net worth Rs m27,1883,020 900.2%   
Long term debt Rs m4,9931,817 274.7%   
Total assets Rs m47,77813,347 358.0%  
Interest coverage x41.71.6 2,684.6%   
Debt to equity ratio x0.20.6 30.5%  
Sales to assets ratio x0.80.9 90.6%   
Return on assets %12.65.4 234.8%  
Return on equity %21.510.0 214.9%  
Return on capital %23.613.3 177.2%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m19,4535,843 332.9%   
Fx outflow Rs m6,0652,173 279.1%   
Net fx Rs m13,3883,669 364.8%   
CASH FLOW
From Operations Rs m8,120398 2,042.2%  
From Investments Rs m-7,556-1,635 462.1%  
From Financial Activity Rs m5901,309 45.1%  
Net Cashflow Rs m1,15371 1,619.8%  

Share Holding

Indian Promoters % 74.1 39.2 189.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 3.6 80.6%  
FIIs % 9.1 17.6 51.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 39.6 35.1%  
Shareholders   49,328 20,750 237.7%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   NATCO PHARMA  FRESENIUS KABI ONCO.  FDC  ABBOTT INDIA  STRIDES PHARMA SCIENCE  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 25, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS